Healthcare
Live Price
Offline$5.26
+0.19% today
1Y Change
+131.88%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
The Oncology Institute, Inc. (TOI) is a Healthcare stock with a market cap of $400.00M and listed on NASDAQ. The stock last traded around $5.26 and up 131.9% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +27.8%, EPS growth of +23.9%, a dividend yield of 0.0%. What stands out right now is revenue +27.8%, EPS +23.9%, free cash flow +8.4% with operating margin -7.2% and ROIC -35.7%. Valuation is more restrained than many high-expectation growth names at price/sales 0.8. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines TOI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TOI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TOI Max Drawdown
-49.79%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TOI and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.